Viewing Study NCT01245803



Ignite Creation Date: 2024-05-05 @ 11:04 PM
Last Modification Date: 2024-10-26 @ 10:28 AM
Study NCT ID: NCT01245803
Status: UNKNOWN
Last Update Posted: 2010-11-23
First Post: 2010-11-22

Brief Title: Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACS
Sponsor: Beijing Anzhen Hospital
Organization: Beijing Anzhen Hospital

Study Overview

Official Title: Acute Rosuvastatin for Preventing Myocardial Damage in Patients With Acute Coronary Syndrome
Status: UNKNOWN
Status Verified Date: 2010-07
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: AVATAR
Brief Summary: Rosuvastatin reload may prevent myocardial damage in ACS patients undergoing PCI
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None